Cutaneous side effects of anti–tumor necrosis factor biologic therapy: A clinical review
- 1 September 2009
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 61 (3), 486-504
- https://doi.org/10.1016/j.jaad.2008.10.060
Abstract
No abstract availableKeywords
This publication has 140 references indexed in Scilit:
- Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapiesJournal of the American Academy of Dermatology, 2007
- Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonistsBritish Journal of Dermatology, 2007
- Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension studyJournal of the American Academy of Dermatology, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy databaseJournal of the American Academy of Dermatology, 2006
- Rapid onset of cutaneous squamous cell carcinoma of the penis in a patient with psoriasis on etanercept therapyJournal of the American Academy of Dermatology, 2004
- Aggressive cutaneous T-cell lymphomas after TNFα blockadeJournal of the American Academy of Dermatology, 2004
- Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2004
- Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximabJournal of the American Academy of Dermatology, 2004
- Eruptive melanocytic nevi in patients with renal allografts: Report of 10 cases with dermoscopic findingsJournal of the American Academy of Dermatology, 2003